<DOC>
	<DOCNO>NCT01520532</DOCNO>
	<brief_summary>The purpose study determine rate diffusion weight ( DW ) -MRI cerebral lesion follow Pulmonary Vein Ablation Catheter ( PVAC ) ablation procedure perform use best practice , include optimized procedural technique anti-coagulation therapy .</brief_summary>
	<brief_title>Evaluation Incidence Cerebral Lesions Post Pulmonary Vein Ablation Catheter ( PVAC )</brief_title>
	<detailed_description />
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Subject least 18 year old Subject diagnose atrial fibrillation ( AF ) Subject indicate pulmonary vein ablation use PVAC Subject ( subject 's legally authorize representative ) able willing give inform consent . Subject permanent AF Subject leave atrial thrombus detect TEE Subject prior leave atrial ablation Subject intracardiac thrombus Subject contraindicate Warfarin ( Coumadin ) Subject cardiac valve prosthesis Subject significant congenital heart defect correct include atrial septal defect pulmonary vein abnormality include minor PFO ) Subject presence pulmonary vein stent Subject presence preexist pulmonary vein stenosis Subject cerebral ischemic event ( strokes transient ischemic attack [ TIA ] ) occur 6 month interval precede Consent Date Subject woman know pregnant Subject unwilling unable comply fully study procedure followup</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2013</verification_date>
</DOC>